hosp:+996506131088
inland:+8613880857038
Online customer service
Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive medicine at the University of South China
· Professional training at Huazhong University of Science and Technology and Tongji Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
          egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
          insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
          disease
          diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
          clinical
          technology applications. Many of these technologies are at the leading level both domestically
          and
          internationally.
Tags:
How to judge and treat the symptoms of asthenospermia in Tulip International Reproductive Center of Kyrgyzstan, IVF in Kyrgyzstan, diagnostic criteria of asthenospermia, interpretation of semen analysis report, ICSI single sperm injection, male infertility treatment process, overseas test tube process, and improvement methods of asthenospermia.
Date:
2026.04.27
Share:
Back to list

Infertility is not a "sensory problem": from detection to intervention, we can understand the judgment and treatment path of Tulip International Reproductive Center in Kyrgyzstan from six key points.

First, definition: how to judge asthenospermia in medicine?



In male fertility assessment, "asthenospermia" is not a subjective judgment, but a medical conclusion based on standardized test data.


According to the Laboratory Manual for Human Semen Examination and Processing (5th edition and subsequent updates) issued by the World Health Organization, sperm motility (that is, the proportion of sperm in forward movement) is one of the core indicators.


Common clinical standards are:


The proportion of forward moving sperm (PR) is less than 32%


Or the proportion of total exercise sperm is less than 40%


When the index is below the above range, it is usually classified as "Asthenozoospermia".


From the first-principles point of view, sperm vitality essentially represents "the ability of sperm to reach the egg".

Even if the number of sperm is normal, but the exercise ability is insufficient, the fertilization probability will be significantly reduced.


Clinical consensus: asthenospermia ≠ complete infertility, but the probability of natural conception is reduced.


Expert tip:

"There are fluctuations in semen indicators, and a single abnormality cannot be directly diagnosed. Usually, it is necessary to review 2-3 times every 2-3 weeks and then make a comprehensive judgment."


面聊410f1c8f026569827a0c3a9698279875.jpg



Second, the process: how to evaluate the tulip international reproductive center in Kyrgyzstan?

Judging from the actual medical treatment path, the judgment of weak sperm is not a single step, but a continuous evaluation process.




1. Preliminary assessment (remote or initial diagnosis)


Medical history collection (living habits, past diseases, pregnancy preparation time)


Analysis of previous semen reports




2. Standardized semen testing


Samples were taken after abstinence for 2–7 days.


Test items include:


Sperm concentration


Vigor (PR, NP)


form




3. In-depth evaluation (if necessary)


Sperm DNA fragmentation rate (DFI)


Hormone levels (FSH, LH, testosterone)


Testicular color Doppler ultrasound




4. Typing judgment

According to the results, asthenospermia is usually further divided into:


Mild (near critical value)


Moderate (significantly decreased)


Severe (almost no sperm moving forward)


This classification directly affects the follow-up treatment path.


The data show that abnormal sperm motility accounts for about 30%-40% of male infertility factors (source: WHO male fertility research data summary).



Third, technology: What is the mainstream treatment path for asthenospermia?

In clinical practice, the treatment of asthenospermia is not a single scheme, but a layered intervention.




Basic conditioning and intervention

Suitable for mild or reversible asthenospermia


Common measures include:


Antioxidant therapy (such as coenzyme Q10, vitamin E, etc.)


Improve lifestyle (quit smoking, control weight)


Avoid high temperature environment (such as sauna and sedentary)


Studies have shown that oxidative stress is one of the important factors affecting sperm motility (source: Andrology journal review).



2. Optimized sperm processing technology

Before entering assisted reproduction, laboratory screening is usually carried out:


density gradient centrifugation


Upstream screening


Objective: To screen sperm with stronger motility and improve the fertilization probability.



3. ICSI single sperm injection technology

When sperm motility is obviously decreased, single sperm microinjection technique is often used in clinic.


Its core logic is:

Bypass the process of "sperm swimming by itself" and complete fertilization directly.


Applicable situation:


Moderate and severe asthenospermia


Sperm quantity and motility are abnormal at the same time.


The data shows that the application ratio of ICSI technology in male factor infertility is increasing year by year (source: ESHRE European Society of Human Reproduction and Embryology report).



4. Auxiliary strategy for embryo screening (according to indications)

In some cases, it will be combined with embryonic genetic testing.


Expert tip:

"Embryo screening is mainly used for risk assessment of chromosomal abnormalities, not for asthenospermia itself, and should be selected strictly according to medical indications."



Fourth, the crowd: who needs to pay more attention to the problem of weak sperm?

From the clinical experience, the following people are more prone to sperm motility decline:




1. Long-term pregnancy unsuccessful population


Try to conceive naturally for more than one year without success.




2. People with lifestyle risk factors


Smoking and drinking


Stay up late for a long time


Working at high temperature or sedentary.




3. Those with a history of reproductive system diseases.


pampinocele


prostatitis




4. Population with increasing age

Although the decline rate of male fertility is slower than that of female, research shows that:

The rate of sperm DNA damage in men over 40 years old has increased significantly (source: Fertility and Sterility journal).



V. Q&A: Analysis of the core questions about weak sperm.


Q1: Can weak sperm get pregnant naturally?

Yes, but the probability is reduced.

Mild asthenospermia still has the chance of natural pregnancy under the condition of precise sexual intercourse during ovulation.



Q2: Do weak sperm have to be a test tube?

Not necessarily.

Depends on:


Sperm motility


Female age and ovarian reserve


Pregnancy preparation time



Q3: How long can conditioning be improved?

It is generally recommended that 3 months be a cycle (the spermatogenesis cycle is about 74 days).

But there are individual differences in the effect.



Q4: Does asthenospermia affect embryo quality?

It may be related, but it is not absolute.

Key influencing factors include:


DNA fragmentation rate


Sperm morphology



Q5: Is overseas assisted reproduction more suitable for asthenospermia?

Essentially, it depends on the technical adaptability, not the region itself.

For example, ICSI technology is mature in the world.



VI. Summary



Around [How to judge and treat asthenospermia symptoms by Tulip International Reproductive Center in Kyrgyzstan], a clear logical chain can be extracted:


1. The core of judgment: based on standardized semen analysis, not subjective feelings.

2. Decision-making key: light and heavy classification determines the path.

3. Treatment strategy: from conditioning to laboratory screening to ICSI escalation.

4. Individual differences: Different groups of people need differentiated programs.


From the perspective of holistic medicine, asthenospermia is not a single disease, but the result of multiple factors.


Summary box:

"The essence of asthenospermia is' functional decline' rather than' ability disappearance'. Scientific evaluation and layered intervention are the key paths to improve fertility opportunities."


Common aliases:Tulip IVF · Tulip Reproductive Center · Kyrgyz Tulip Hospital · Tulip Fertility Center

🏥 Located in downtown Bishkek, the capital of Kyrgyzstan, near the National Museum and Victory Square. It is the first Chinese-invested, officially licensed assisted reproductive hospital in the country. Founded and directly operated by Mr. Chen Yinuo (EnoChan), the center specializes in high-level fertility services including PGT (3rd generation IVF) and legal third-party reproduction for global clients, especially Chinese patients.

Expert Team
& Special Services

  • Senior Specialists
    ART review experts, postdoctoral fellows, and reproductive physicians with 10+ years of experience, offering MDT approach.
  • Full Chinese Support
    From consultation to post-return documentation, a dedicated Chinese-speaking team assists with legal processes for "Chinese babies returning home".
  • Personalized Plans
    Tailored fertility protocols based on individual medical conditions and needs, with 1-on-1 medical advisory.

Core Medical
& Technical Advantages

  • 3rd Gen IVF (PGT)
    Screens genetic disorders, improves implantation success.
  • IVM Technology
    In vitro maturation of immature oocytes, ideal for advanced age or poor egg quality.
  • Legal Third-Party Reproduction
    Protected by local laws, serving singles, LGBTQ+ and diverse needs.
  • Fertility Preservation
    Egg/embryo freezing, sperm/egg donation services.
World-Class Clinical Data
92.4%
Blastocyst Transfer Success
(clinical pregnancy/transfer cycle)
88.75%
Blastocyst Formation Rate
(from mature oocytes)
📊 Period: Oct 2025 – Mar 2026 | Data from our embryology lab annual report

Official Contact Channels

Official Websitewww.ivftulip.com
Only WeChat ConsultationTulip_EnoChan
Mainland China Mobile13880857038 (+86)
Mainland China Landline400-060-0670
Local number in Kyrgyzstan: +996 506131088 (backup)

相关新闻

Learn more